AMINDER S MEHDI MD NPI 1780612507

NPI Information

  • NPI: 1780612507
  • Provider Name: AMINDER S MEHDI, MD
  • Classification: Specialist - 174400000X
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2626 N CALIFORNIA ST
    SUITE B
    STOCKTON, CA
    ZIP 95204
  • Phone: (209) 466-2626

Map and Directions

Get Directions

NPI Details

Aminder S Mehdi, MD is a specialist in Stockton, CA with 49 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. Aminder S Mehdi, MD NPI is 1780612507. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

2626 N CALIFORNIA ST
SUITE B
STOCKTON, CA
ZIP 95204-500
Phone: (209) 466-2626
Fax: (209) 466-7153

The NPI 1780612507 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)

The enumeration date for this NPI number is 6/29/2006 and was last updated on 3/9/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1174400000XSpecialistA43019CALIFORNIAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.